Related Experiment Videos
Co-infection or early superinfection of pneumococcal pneumonia
B Riou1, C Richard, A Rimailho
1Department of Critical Care Medicine, Hôpital de Bicêtre, University of Paris-Sud, France.
Abstract:
Two cases of co-infection or very early superinfection of pneumococcal pneumonia with Staphylococcus aureus in one case, and Enterobacter cloacae in the other, are reported. The two patients were not fully immunocompetent, had leukopenia and a mild intravascular coagulation, and were bacteremic. Mixed infection probably accounted for the lethal outcome because initial antibiotherapy was only directed against Streptococcus pneumoniae. Accurate bacteriologic methods are required to delineate contaminating and infecting pathogens when another bacteria is found in initial bronchial samples of patients with pneumococcal pneumonia, and the antibiotherapy might be directed against the two pathogens until quantitative bacteriologic results would be available, especially in old and debilitated patients. The incidence of mixed infection in pneumococcal pneumonia seems low.
Insights
Pneumococcal pneumonia can present with secondary bacterial infections, complicating treatment. Early broad-spectrum antibiotics are crucial for better outcomes in vulnerable patients with mixed infections.
Area of Science:
- Infectious Diseases
- Bacteriology
- Clinical Medicine
Background:
- Pneumococcal pneumonia is a common bacterial infection.
- Co-infections or superinfections can alter disease presentation and outcomes.
- Immunocompromised status and underlying health conditions increase susceptibility.
Observation:
- Two cases of pneumococcal pneumonia with secondary infections by Staphylococcus aureus and Enterobacter cloacae were observed.
- Both patients presented with leukopenia, mild intravascular coagulation, and bacteremia.
- These patients were not fully immunocompetent, suggesting increased vulnerability.
Findings:
- Mixed infections likely contributed to the fatal outcomes in these cases.
- Initial antibiotic therapy targeting only Streptococcus pneumoniae proved insufficient.
- Accurate and rapid bacteriologic diagnostics are essential for identifying all causative pathogens.
Implications:
- Antibiotic strategies should consider potential co-infections, especially in high-risk patients.
- Prompt identification of secondary pathogens is critical for effective treatment.
- Further research into the incidence and impact of mixed infections in pneumococcal pneumonia is warranted.